About US
Contact us
-
Roche snags coveted Polivy win in newly diagnosed lymphoma. But is it enough to change 2 decades of established treatment practices?After two years of meager sales for Polivy, Roche is trumpeting a much-coveted clinical win that could open up a blockbuster market for the drug. Still, questions remain about the exact size of the o2021/8/10
-
FDA expands EUA for Lilly-Incyte’s baricitinib as Covid-19 monotherapyThe US Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for Eli Lilly and Incyte’s drug, baricitinib, for Covid-19 treatment with or without remdesivir. Discovere2021/8/4
-
Takeda and Frazier to launch HilleVax for norovirus vaccine developmentTakeda Pharmaceutical and Frazier Healthcare Partners have partnered to launch a biopharmaceutical company named HilleVax to develop and market Takeda’s norovirus vaccine candidate, HIL-214 (previous2021/8/4
-
Astellas and Minovia enter deal for mitochondrial cell therapiesMinovia Therapeutics and Astellas Pharma have signed a global strategic partnership and licence agreement to research, develop and market new cell therapy programmes for mitochondrial dysfunction-dri2021/8/2
-
Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed termsFor nearly four years, pharmaceutical heavyweights Johnson & Johnson and Pfizerhave sparred in court over competitive dynamics of the biosimilar industry, demanding the attention of the industry2021/7/28
-
Pfizer, Mylan escape another EpiPen lawsuit after judge scraps pharmacy chain's antitrust complaintsMylan and Pfizer have spent years defending their marketing of thepopular epinephrine injector EpiPen. After a busy couple of monthsin court, the partnershave now wipedtheir hands of another lawsuit.2021/7/28
-
Purdue points to creditor support for bankruptcy plan to escape opioid litigation but will Congress followAs if partaking in the powerful drug it aggressively marketed, being at the forefront of the opioid boom was a dizzying high for Purdue Pharma. But it ultimately proved crippling for the manufacturer2021/7/26
-
Lawmakers press FDA for answers about its plans to restart foreign inspectionsFDA inspections restarted earlier this month in the United States, finally giving the regulator a chance to work through the enormous domestic backlog which accumulated during the coronavirus pandemi2021/7/26
-
Johnson & Johnson eyes $2.5B in COVID vaccine sales as key immunology, oncology meds trounce expectationsJohnson & Johnson certainly hasn't had the easiest COVID-19 shotrollout. Still,with sales predictions ranging in the billions and a series of manufacturing improvements ongoing, the company sees2021/7/22
-
With Biovac agreement, Pfizer and BioNTech extend their COVID-19 vaccine manufacturing network to AfricaBypassing patent protections on coronavirus vaccines was one proposal floated in recent months to boost supplies in poor countries.But it’s not a short-term solution and, as some analysts suggest, it2021/7/22